Adam Fraser is the host of the Business of Neurotech Podcast.

In his day job, Adam deftly navigates the complex waters of AI and healthcare as Chief Operating Officer of Omniscient Neurotechnology (o8t®), a global company revolutionizing brain health through the field of connectomics. With over 25 years of experience in finance, private equity and technology, Adam excels in scaling innovative startups and driving operational excellence. He previously served as Director of Business Transformation at EY, as well as holding senior leadership roles in finance and IT in both public and private organisations throughout his career.

Omniscient is a global leader in the field of connectomics, using AI and MRI technology to map and analyse the brain’s intricate network of connections. Omniscient’s FDA-cleared platform, Quicktome®, provides clinicians with critical insights to guide prognosis and treatment across a range of neurological conditions. Looking ahead, Omniscient’s technology stands to transform brain health by enabling truly personalized care for patients impacted by Alzheimer’s, stroke, depression, and beyond.